BPA Call HHSI249200810016B-HHSI2498100160002

This delivery order, valued at $44,179.34, awards Amerisourcebergen Drug Corp the supply of Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, and represents a firm fixed-price procurement with no set-aside designation. The Defense Logistics Agency, under the Department of Defense, is the funding federal agency, and the place of...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of VIVITROL 380 mg vial-diluents. This competitive award, utilizing firm fixed-price pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The delivery order carries an ultimate completion date of...

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply VIVITROL 380 MG VIAL-DILUENTS. The $2,269.15 order, which has no set-aside designation, is to be completed by December 26, 2023. AmerisourceBergen Drug Corp, through its Corporate Office division, is an experienced provider of pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense....

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,820.21 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of June 11, 2025 and does not have a set-aside designation, indicating open competition....

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,828.64 firm-fixed-price contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The award has a completion date of September 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...

This federal contract award is a delivery order with a firm fixed price of $2,002.34 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, with an ultimate completion date of May 19, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,512.47 contract is for the provision of Orencia Clickject 125 mg/mL, a biologic medication used to treat autoimmune conditions. The contract has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024 without any set-aside designation. As a prime contractor to...

<p>The National Institute on Drug Abuse issued a delivery order to Vitae Enim Vitae Scientific, Inc. on September 27, 2024, under the Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products IDIQ for dosage form reprocess and stability studies of FX-5A injection.</p> <p>The order carries a ceiling value of $382,010 under firm fixed price terms. Place of performance is San Diego, CA 92109. Work is scheduled for completion by May 31, 2028.</p>

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $6,213.26 contract is for the delivery of HUMIRA PEN 40 MG/0.8 MLS, a biologic drug used to treat autoimmune conditions. This contract does not have a set-aside designation and is part of the DLA Troop Support Medical's efforts to maintain comprehensive...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,989.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication used to treat various autoimmune conditions. This firm fixed-price contract, awarded November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing indefinite delivery contract with DLA Troop...